DFFN Diffusion Pharmaceuticals Inc. Stock Quote

DFFN [NASD]

Index	-	P/E	-	EPS (ttm)	-11.91	Insider Own	0.10%	Shs Outstand	2.04M	Perf Week	3.72%
Market Cap	15.93M	Forward P/E	-	EPS next Y	-7.33	Insider Trans	0.00%	Shs Float	2.04M	Perf Month	1.69%
Income	-24.00M	PEG	-	EPS next Q	-2.04	Inst Own	8.80%	Short Float	4.08%	Perf Quarter	-38.84%
Sales	-	P/S	-	EPS this Y	17.70%	Inst Trans	-7.23%	Short Ratio	0.97	Perf Half Y	-61.07%
Book/sh	15.02	P/B	0.52	EPS next Y	11.80%	ROA	-58.10%	Target Price	40.00	Perf Year	-77.43%
Cash/sh	15.98	P/C	0.49	EPS next 5Y	-	ROE	-62.40%	52W Range	5.10 - 42.76	Perf YTD	-48.79%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-82.39%	Beta	1.46
Dividend %	-	Quick Ratio	11.40	Sales past 5Y	-	Gross Margin	-	52W Low	47.65%	ATR	1.02
Employees	16	Current Ratio	11.40	Sales Q/Q	-	Oper. Margin	-	RSI (14)	45.22	Volatility	8.62% 12.73%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	20.20%	Profit Margin	-	Rel Volume	0.04	Prev Close	7.81
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 12 AMC	Payout	-	Avg Volume	85.67K	Price	7.53
Recom	3.00	SMA20	6.42%	SMA50	-24.78%	SMA200	-57.01%	Volume	211	Change	-3.59%

Nov-17-20

Downgrade

H.C. Wainwright

Buy → Neutral

Mar-21-18

Initiated

H.C. Wainwright

Buy

$1.25

May-20-22 08:10AM	DFFN: Data from Altitude Trial Expected in June 2022 Zacks Small Cap Research
May-18-22 07:30AM	Diffusion Pharmaceuticals Announces Appointment of Raven Jaeger, M.S., as Chief Regulatory Officer GlobeNewswire -6.65%
May-17-22 07:30AM	Diffusion Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference GlobeNewswire
May-12-22 04:05PM	Diffusion Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update GlobeNewswire +5.67%
May-04-22 07:20AM	Diffusion Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements GlobeNewswire
Apr-18-22 10:42AM	Diffusion Pharmaceuticals' 50-For-1 Stock Split Will Go Into Effect Tomorrow Benzinga -34.22%
09:20AM	Diffusion Pharmaceuticals Announces 1-for-50 Reverse Stock Split as Part of Nasdaq Compliance Plan GlobeNewswire
Apr-11-22 07:20AM	Diffusion Pharmaceuticals Completes Dosing in Altitude Trial GlobeNewswire
Apr-08-22 07:20AM	Diffusion Pharmaceuticals Announces New Date for Previously Announced Special Meeting of Stockholders GlobeNewswire
Apr-06-22 10:15AM	10 Biotech Penny Stocks with Growth Catalysts Insider Monkey
Mar-23-22 10:20AM	DFFN: Additional Tissue Oxygenation Trial Results Expected Mid-2022 Zacks Small Cap Research +29.98%
Mar-21-22 07:20AM	Diffusion Pharmaceuticals Reports 2021 Financial Results and Provides Business Update GlobeNewswire
Mar-09-22 04:56AM	We're Keeping An Eye On Diffusion Pharmaceuticals' (NASDAQ:DFFN) Cash Burn Rate Simply Wall St. +5.31%
Feb-24-22 07:02AM	Diffusion Pharmaceuticals Expands its Scientific Advisory Board with the Addition of Leading Radiation and Medical Oncology Experts GlobeNewswire
Dec-20-21 07:02AM	Diffusion Pharmaceuticals to Present at H.C. Wainwright BioConnect, Participate in Biotech Showcase and Bio Partnering at JPM during J.P. Morgan Week 2022 GlobeNewswire
Dec-16-21 08:59AM	Diffusion Pharmaceuticals Doses First Patients in ILD-DLCO Trial GlobeNewswire
Dec-01-21 07:02AM	Diffusion Pharmaceuticals Announces Issuance of U.S. Patent 11,185,523 GlobeNewswire
Nov-30-21 11:57AM	10 Biotech Penny Stocks to Buy Now Insider Monkey -8.16%
Nov-29-21 06:27AM	DFFN: TSC to be Developed for Treatment of Hypoxic Tumors Zacks Small Cap Research
Nov-22-21 07:02AM	Diffusion Pharmaceuticals Doses First Participants in Altitude Trial GlobeNewswire -8.51%
Nov-10-21 07:02AM	Diffusion Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update GlobeNewswire
Oct-28-21 07:30AM	Diffusion Pharmaceuticals to Participate in the Alliance Global Partners Biotech & Specialty Pharma Conference GlobeNewswire
Sep-10-21 07:02AM	We're Not Very Worried About Diffusion Pharmaceuticals' (NASDAQ:DFFN) Cash Burn Rate Simply Wall St.
Sep-09-21 07:32AM	Diffusion Pharmaceuticals Issues Letter to Shareholders GlobeNewswire
Sep-08-21 07:32AM	Diffusion Pharmaceuticals to Present at the 23rd Annual H.C. Wainwright Global Investment Conference GlobeNewswire
Aug-30-21 07:32AM	Diffusion Pharmaceuticals Announces Clearance of IND Application for TSC by FDAs Pulmonology, Allergy, and Critical Care Division GlobeNewswire +10.20%
Aug-19-21 06:05AM	DFFN: Initial Indication for TSC to be Announced 4Q21 Zacks Small Cap Research
Aug-11-21 07:32AM	Diffusion Pharmaceuticals Reports Q2 Financial Results and Provides Business Update GlobeNewswire -5.27%
Aug-06-21 10:20AM	10 Biotech Penny Stocks to Buy According to Reddit Insider Monkey
Jul-06-21 06:34AM	DFFN: TSC Causes Dose Dependent Increase in Tissue Oxygenation in TCOM Trial Zacks Small Cap Research
Jun-30-21 11:14AM	Diffusion Pharma's TSC Shows Encouraging Effects On Oxygenation Benzinga
07:35AM	Diffusion Pharmaceuticals Reports Positive Trend in Oxygenation from TCOM Trial GlobeNewswire
Jun-28-21 08:35AM	Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing GlobeNewswire
Jun-21-21 08:35AM	Virtual Conference for Life Sciences Companies Broadcast Live June 24th, 2021 GlobeNewswire
07:35AM	Diffusion Pharmaceuticals to Webcast Live at Life Sciences Investor Forum GlobeNewswire
Jun-18-21 07:35AM	Diffusion Pharmaceuticals Reminds Stockholders to Vote Shares In Advance of Annual Meeting GlobeNewswire
Jun-13-21 06:13PM	Diffusion Pharmaceuticals Inc. (DFFN): Hedge Funds In Wait-and-See Mode Insider Monkey
May-14-21 08:21AM	DFFN: Encouraging Data for TSC in COVID-19 Patients Zacks Small Cap Research
May-10-21 10:23AM	Diffusion Pharma's Trans Sodium Crocetinate Associated With Improved Outcomes In COVID-19 Patients Benzinga +12.85%
07:50AM	Diffusion Pharmaceuticals Reports Final Results from Its Phase 1b Study of Trans Sodium Crocetinate in Hospitalized COVID-19 Patients GlobeNewswire
07:05AM	Diffusion Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update GlobeNewswire
Mar-25-21 11:47AM	DFFN: Three Studies to Guide Clinical Development of TSC Zacks Small Cap Research
11:15AM	DFFN: Three Studies to Guide Clinical Development of TSC Zacks Small Cap Research
09:01AM	Diffusion Pharmaceuticals Completes Enrollment and Dosing in TCOM Study GlobeNewswire
08:45AM	DFFN: Three Studies to Guide Clinical Development of TSC Zacks Small Cap Research
Mar-18-21 07:05AM	Diffusion Pharmaceuticals Doses First Participants in TCOM Study GlobeNewswire
Mar-17-21 07:05AM	Diffusion Pharmaceuticals Reports 2020 Financial Results and Provides Business Update GlobeNewswire +5.88%
Mar-14-21 04:47AM	We're Not Very Worried About Diffusion Pharmaceuticals' (NASDAQ:DFFN) Cash Burn Rate Simply Wall St.
Mar-04-21 04:05PM	Diffusion Pharmaceuticals, Inc. to Present at the H.C. Wainwright Global Life Sciences Conference GlobeNewswire -12.14%
Feb-18-21 04:05PM	Diffusion Pharmaceuticals Announces Full Exercise of Underwriters Option to Purchase Additional Shares of Common Stock GlobeNewswire
Feb-17-21 04:13PM	Diffusion Pharmaceuticals Announces Closing of $30 Million Bought Deal Offering of Common Stock GlobeNewswire -12.35%
07:26AM	The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal Benzinga
Feb-16-21 09:18AM	Diffusion Pharma Climbs After Completing Early-Stage TSC Study In COVID-19 Patients Benzinga +37.10%
07:35AM	Diffusion Pharmaceuticals Completes Phase 1b Study of TSC in Hospitalized COVID-19 Patients GlobeNewswire
Feb-11-21 10:02PM	Diffusion Pharmaceuticals Increases Previously Announced Bought Deal Offering of Common Stock to $30 Million GlobeNewswire
05:54PM	Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock GlobeNewswire
Jan-11-21 07:30AM	Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference GlobeNewswire +34.02%
Dec-04-20 07:20AM	DFFN: Planning for Additional Studies of TSC Zacks Small Cap Research +8.30%
Nov-29-20 07:29PM	Is Diffusion Pharmaceuticals Inc. (DFFN) A Good Stock To Buy? Insider Monkey
Nov-18-20 11:55AM	Insider Buys Diffusion Pharmaceuticals Shares Benzinga
Nov-12-20 04:02PM	Diffusion Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Updates GlobeNewswire
Oct-19-20 08:00AM	Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer GlobeNewswire
Sep-24-20 08:00AM	Diffusion Pharmaceuticals Strengthens Management Team with Appointment of William Elder as General Counsel and Corporate Secretary GlobeNewswire
Sep-17-20 03:40PM	DFFN: First Patients Dosed in COVID-19 Trial Zacks Small Cap Research
Sep-15-20 07:12AM	We Think Diffusion Pharmaceuticals (NASDAQ:DFFN) Can Afford To Drive Business Growth Simply Wall St.
Sep-11-20 08:30AM	Diffusion Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Virtual Global Investment Conference GlobeNewswire +7.53%
Sep-10-20 08:00AM	Diffusion Pharmaceuticals Doses First Two Patients with TSC in COVID-19 Clinical Trial GlobeNewswire
Sep-08-20 04:02PM	Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer GlobeNewswire -7.53%
Sep-01-20 04:02PM	Diffusion Pharmaceuticals Appoints Jane H. Hollingsworth to its Board of Directors GlobeNewswire -7.10%
Aug-24-20 08:32AM	DFFN: ARDS Trial Set to Get Underway Zacks Small Cap Research -6.31%
Aug-10-20 08:00AM	Diffusion Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
Jul-27-20 08:00AM	Diffusion Pharmaceuticals Receives FDA Guidance for International Phase 1b/2b COVID-19 Clinical Program with TSC GlobeNewswire -13.64%
Jul-07-20 08:00AM	Diffusion Pharmaceuticals Files IND for International Phase 1b/2b COVID-19 Clinical Program With TSC GlobeNewswire
Jul-06-20 07:47PM	3 Coronavirus Penny Stocks With Triple-Digit Upside Potential TipRanks
Jun-11-20 08:00AM	Diffusion Pharmaceuticals Files Clinical Trial Application for European Phase 1a/1b Study of TSC in COVID-19 Patients GlobeNewswire -5.56%
Jun-01-20 08:00AM	Diffusion Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement GlobeNewswire
May-26-20 08:00AM	Diffusion Pharmaceuticals Receives Accelerated FDA Response to Proposed TSC COVID-19 Clinical Trial Program GlobeNewswire
May-20-20 01:00PM	Diffusion Pharmaceuticals Inc. Announces Closing of $12.0 Million Registered Direct Offering Priced At-the-Market GlobeNewswire
08:00AM	Diffusion Pharmaceuticals Expands Clinical Trial Program of TSC for the Treatment of COVID-19 Patients to Include the Romanian National Institute of Infectious Diseases GlobeNewswire
May-19-20 03:18PM	Johns Hopkins doctor on Trump's preventative hydroxychloroquine use: 'hopefully other people will not follow this example' Yahoo Finance Video
09:05AM	DFFN: TSC to be Tested as Treatment for ARDS Caused by COVID-19 Zacks Small Cap Research
May-18-20 09:05AM	Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules GlobeNewswire -17.78%
May-11-20 04:11PM	Diffusion Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update GlobeNewswire +20.53%
May-05-20 08:00AM	Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS GlobeNewswire +11.97%
Apr-27-20 08:00AM	Diffusion Pharmaceuticals Announces Pre-IND Submission to the FDA of Design for TSC Trials to Treat Acute Respiratory Distress Syndrome in COVID-19 GlobeNewswire +14.07%
Apr-03-20 07:30AM	DFFN: Evaluating TSC as Potential Treatment for ARDS Zacks Small Cap Research
Apr-01-20 08:00AM	Diffusion Pharmaceuticals Evaluating TSC Against Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients GlobeNewswire +61.09%
Mar-24-20 04:05PM	Diffusion Pharmaceuticals Anticipates Enrollment in its Ambulance-based Stroke Trial Will be Slowed Due to the Impact of the Coronavirus GlobeNewswire
Mar-19-20 07:28AM	Is Diffusion Pharmaceuticals (NASDAQ:DFFN) In A Good Position To Deliver On Growth Plans? Simply Wall St.
Mar-18-20 06:35PM	CORRECTION -- Diffusion Pharmaceuticals Reports 2019 Financial Results and Provides Business Update GlobeNewswire
Mar-17-20 04:10PM	Diffusion Pharmaceuticals Reports 2019 Financial Results and Provides Business Update GlobeNewswire +9.53%
Mar-12-20 08:00AM	Diffusion Pharmaceuticals Announces Retirement of Chief Science Officer John L. Gainer GlobeNewswire -14.97%
Feb-07-20 08:30AM	Diffusion Pharmaceuticals Receives European Patent Related Compositions of TSC GlobeNewswire -7.16%
Jan-10-20 08:00AM	Diffusion Pharmaceuticals Appoints Life Sciences Veteran Dr. Robert Cobuzzi, Jr. to its Board of Directors GlobeNewswire +6.55%
Dec-30-19 08:00AM	DFFN: Highly Encouraging Data from Run-in Portion of Phase 3 GBM Trial Zacks Small Cap Research
Dec-22-19 06:43PM	Hedge Funds Have Never Been More Bullish On Diffusion Pharmaceuticals Inc. (DFFN) Insider Monkey
Dec-13-19 02:07PM	Diffusion Pharmaceuticals Inc. Announces Closing of $3.5 Million Offering Priced At-the-Market GlobeNewswire
Dec-12-19 09:55AM	CORRECTING and REPLACING Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market GlobeNewswire -24.51%
08:00AM	Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market GlobeNewswire
Dec-11-19 07:21AM	The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint Benzinga +31.40%

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience